Recall of Medtronic MiniMed Insulin Reservoirs

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Medtronic Australasia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class I
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    There is the potential that reservoirs from the affected batches may have an increased risk of leaking. a leak in the reservoir may result in delivery of less insulin than needed. in addition, if the user has a leaky reservoir and an insulin blockage occurs in the infusion set, the pump may not alarm to notify them.
  • Action
    Medtronic Diabetes is requesting customers to not use reservoirs from the affected batch. If no alternative product is available, customers are requested to switch to their back-up insulin injection plan. Replacement of affected batches can be arranged by contacting the Medtronic 24 Hour Help Line. For more details, please see .


  • Model / Serial
    Medtronic MiniMed Insulin ReservoirsModel Numbers: MMT-326A and MMT-332ABatch Numbers: H8442973, H8463297, H8467888, H8469703, H8473271, H8478398, H8492449, H8494645, H8496561, H8510440, H8512826, H8517079, H8539013 and H8627745ARTG Number: 169959
  • Product Classification
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source